NCT05431712View on ClinicalTrials.gov

Impact of Donor-Specific Antibodies in (Highly-) Immunized Living Donor Kidney Transplant Recipients

CompletedOBSERVATIONAL
Enrollment

252

Participants

Timeline

Start Date

January 1, 2010

Primary Completion Date

December 31, 2019

Study Completion Date

December 31, 2019

Conditions
Renal Failure
Sponsors
All Listed Sponsors
lead

Erasmus Medical Center

OTHER

NCT05431712 - Impact of Donor-Specific Antibodies in (Highly-) Immunized Living Donor Kidney Transplant Recipients | Biotech Hunter | Biotech Hunter